Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level.
Jiang
Jun-Lin
JL
Zhu
Hui-Qing
HQ
Chen
Zhou
Z
Xu
Hai-Yuan
HY
Li
Yuan-Jian
YJ
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood / Q000187:drug effects; D002216:Captopril / Q000494:pharmacology*; D008078:Cholesterol, LDL / Q000008:administration & dosage / Q000187:drug effects*; D004656:Enalapril / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000503:physiopathology; D023421:Models, Animal; D051381:Rats
D000806:Angiotensin-Converting Enzyme Inhibitors; D008078:Cholesterol, LDL; C487735:dimethylarginine; D004656:Enalapril; D001120:Arginine; D002216:Captopril